Login / Signup

Oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial.

Mohammad Hossein SharifMohammad Reza TalebnejadKarim RastegarMohammad Reza KhaliliMohammad Hossein Nowroozzadeh
Published in: Eye (London, England) (2019)
This study suggests beneficial effects of fluoxetine in the management of adult and adolescent amblyopia.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • young adults
  • mental health
  • peritoneal dialysis
  • childhood cancer
  • patient reported outcomes